Orthopaedics Stem Cell Therapy at Giostar – Patient Testimonial
Dear Dr. Anand S Srivastava,
We are very pleased to inform you that your manuscript has successfully gone through all the required processes for publication. Certainly, your article deserves its place on the JSRT’s bookshelf, and we will do our best to share your endeavors with the world. That’s a promise.
Again, congratulations! We appreciate you choosing JSRT as a venue for sharing your article with the world.
Open Journal of Organ Transplant Surgery (OJOTS)
|Dear Anand S Srivastava,|
In view of your valuable publications in academic circle, we hereby invite you to submit your current scientific manuscripts to “Open Journal of Organ Transplant Surgery” ( ISSN Online: 2163-9493), a peer-reviewed open-access journal.
|The manuscripts are expected to be submitted through our Manuscript Tracking System. If you have difficulties in logging in our Online Submission System, please send the papers directly to this e-mail (unified naming format of mail theme: 209 – “Article Title”), we will upload your papers to our system within 24 hours.|
Potential Topics (not limited to)
|Allograft and allotransplantation||Isograft|
|Cadaveric (non-living) donors||Split transplants|
|Domino transplants||Xenograft and xenotransplantation|
|Published Articles in OJOTS|
|Antimicrobial Effect of Skin for Allograft and Management in Burn Wound
Kihwan Lim, Cheonjae Yoon, Jungsuk Lee
|A Modified, Rapid and Safe Technique of Kidney Only Procurement from Donors after Circulatory and Brain Death (DCD, DBD)
André G. Baranski, Hwai-Ding Lam
|The Effect of Non-Invasive Goal Directed Fluid Administration on Graft Function in Deceased Donor Renal Transplantation: A Pilot Study
Joseph R. Whiteley, Jason M. Taylor, John J. Freely Jr., Thomas I. Epperson, Laura Bell, John L. Murray IV, Charles F. Bratton, William R. Hand
|Deadline: July 25th, 2017|
|Publication Date: August 2017|
|There is no charge for publishing articles in this journal now|
|Prof. Rubin Zhang (Tulane University, USA)|
|OJOTS Editorial Office|
Dear Anand S. Srivastava,
Hope you everything goes well.
I apologize for the inconvenience if the letter disturbed you more than once due to the non-feedback of last one.
It is our great pleasure to welcome you to join the 15th Annual Congress of International Drug Discovery Science & Technology – Japan 2017 (IDDST-Japan 2017) with the theme “Dedicated to Accelerating Drug Innovation”, which will be held during July 25-27, 2017 at Osaka, Japan. And we cordially invite you to propose a Speech on your recent drug discovery project in the field ofTherapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine… for the Section 2: Discovery Chemistry & Drug Design at IDDST-Japan 2017. Your prompt reply with a speech proposal (Speech Title and abstract preferred along with full CV) will be highly appreciated!
IDDST-Japan 2017 covers Keynote Forum and 6 Parts, totally 30 Sessions as well as other exciting social events. So far, we have received more than 500 positive feedbacks by industrial and academic experts all of the world, and almost 100 excellent speakers already registered and confirmed their participation. Please find part of confirmed speakers as below. The full program has been released online and you may check more information of potential speakers and theirnovel topics! As we still have about 4 months to the event, we believe the IDDST-Japan 2017 will be the most successful annual conference than ever!
We sincerely hope you can join in us next July, please kindly let us know your opinion. Look forward to seeing you in amazing OSAKA for a stimulating and enjoyable conference!
Ms. Irene Wang
Organizing Committee of IDDST-Japan 2017
Part of Confirmed Speakers in Business
Dr. Helmut Haning, Senior Vice President, Bayer Pharma Aktiengesellschaft, Germany
Dr. Litao Zhang, Vice President & Leads Discovery Optimization, Bristol-Myers Squibb, USA
Dr. Akiyoshi Suganuma, Group Officer, BA-CFU President, Eisai Co., Ltd., Japan
Dr. David C. Bunton, CEO, ReproCELL Group Companies, Japan
Dr. Giovanna Bergamini, Director Discovery Biology and GSK Fellow, GSK, Germany
Dr. Dinah Weissmann, Executive VP R&D, Alcediag, France
Dr. Teresa Tarrago, Chief Executive Officer, Iproteos S.L., Spain
Dr. Joseph P. Thomas, Chair of the Life Sciences Group and Co-chair of the Litigation Department, Ulmer & Berne LLP, USA
Dr. Graeme Ladds, Operations Director & CEO, PharSafer Associates Ltd, USA
Dr. Helmut Thomas, President and CEO, Cyclenium Pharma Inc., Canada
Dr. Gerhard Muller, Senior Vice President, Mercachem, The Netherlands
Dr. Junsang Park, Vice President, GL PharmTech, South Korea
Dr. Dieter Lubda, Director, Actives & Formulation R&D Operations, Merck KGaA, Germany
Dr. Fredrik Sundberg, Global Director, GE Healthcare, Sweden
Dr. Shu-Hui Liu, Director, Pfizer Inc., USA
Dr. Jean-Christophe Carry, Group Leader, Medicinal Chemistry, Sanofi, France
Dr. Andreas Haupt, Associate Director, Department of Medicinal Chemistry, AbbVie Deutschland GmbH & Co. KG, Germany
Dr. Stefan Bassarab, Senior Manager, Drug Product Development and Drug Delivery, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Dr. Lars Barfacker, Principal Scientist, Bayer Pharma, Germany
Dr. Andrzej Joachimiak, Program Director, Structural Biology Center, Argonne National Laboratory; Sr. Biophysicist, Argonne, USA
Dr. Gary Henniger, Director Engineering, Teva Global Respiratory R&D, Israel
Part of Confirmed Speakers in Academia
Dr. Paul L. Kaufman, Professor, University of Wisconsin-Madison, USA
Dr. Martin Dawes, Royal Canadian Legion Professor and Head, Department of Family Practice, The University of British Columbia, Canada
Dr. William Lawson, Professor & Associate Dean for Health Disparities, The University of Texas at Austin, USA
Dr. Branko Stefanovic, Professor, Florida State University, USA
Dr. Shaker A. Mousa, Vice Provost for Research Professor of Pharmacology, Albany College of Pharmacy and Health Sciences, USA
Dr. Youla S. Tsantrizos, Professor, McGill University, Canada
Dr. Randolph D Glickman, Professor, University of Texas Health Science Center, USA
Dr. Magdy El-Salhy, Professor, University of Bergen, Norway
Dr. Nissim Garti, Professor, The Institute of Chemistry, s, Israel
Dr. Hongtao Jin, Associate Professor and Vice Director, New Drug Safety Evaluation Center (NDSEC), Chinese Academy of Medical Sciences & Peking Union Medical College, China
Dr. Tsuchida Kunihiro, Professor, Fujita Health University, Japan
Dr. Dmitry Aminin, Head, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Russia
Dear Dr. Anand S. Srivastava,
I’m writing to follow-up my last invitation as below, would you please give me a tentative reply? Thank you very much. I apologize for the inconvenience if the letter disturbed you more than once.
It is our great pleasure and privilege to welcome you to join the 8th World Gene Convention-2017, which will take place in Macao, China during November 13-15, 2017. We would like to welcome you to be the chair/speaker in Theme 706: Stem Cells, Regenerative Medicine, Tissue Engineering while presenting about Stem Cells, Regenerative Medicine, Tissue Engineering….
If the suggested thematic session is not your current focused core, you may look through the whole sessions and transfer another one that fit your interest (more info about the program is available at http://www.bitcongress.com/wgc2017/ProgramLayout.asp
Under our SAB members’ contributions and endeavor, BIT’s 7th World Gene Convention-2016 (WGC-2016), successfully held in Shanghai, China during November 13-15, 2016. Totally, there were nearly 300 world-renowned experts, professors, laboratory principals, project leaders and representatives of well-known enterprises attended the WGC-2016. Participants from the international enterprises, academic and research institutions enjoyed the three days scientific program. Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing WGC-2017 which would be better and more successful than WGC-2016.
WGC-2017 features a very strong technical program, mainly focused on: breakthroughs in gene, advances genomics & genetics, new research of DNA and RNA, focus on basic research, the frontier research of life sciences, new biotherapy discovery, emerging areas for medicine applications, robust technology development, and cutting-edge Biotechnology. It aims to provide a platform for all experts from academia, industry and national labs to discuss latest hot researches and achievements. Attendees will hear world-class speakers discussing the challenges and opportunities facing the gene, biotechnology and life sciences field. The business & academic experts who are from home and abroad will give excellent speeches.
In addition to the dynamic scientific program, you will benefit from the wonderful experience in Macao, China. Macao is an international free port. It’s famous for light industry, tourism, and hotel. Macao is also one of the most developed and richest regions in the world, this is a city of amazing and fascinating cultural wealth. The unique blend of European and Oriental cultures existing here creates a pleasurable and laid back atmosphere in a truly beautiful city. We hope you will enjoy your stay in this beautiful city with all its feature, beauty, architecture and hospitality!
We expect your precious comments or suggestions; also your reference to other speakers will be highly appreciated. We look forward to receiving your replies on the following questions:
1. What is the title of your speech?
2. Do you have any suggestions about our program?
For more information, please visit the conference website http://www.bitcongress.com/wgc2017/default.asp
We look forward to see you in Macao in 2017 for this influential event.
Ms. Teresa Xiao
Organizing Committee of WGC-2017
East Area, F11, Building 1,
Dalian Ascendas IT Park,
1 Hui Xian Yuan,
Dalian Hi-tech Industrial Zone,
LN 116025, China
Tel: 0086-411-84799609 EXT 826
World Congress of Biomedical Engineering-2017
Theme:Co-creating a New Future of Biomedicine
Time:November 9-11, 2017 Place: Xi’an, China
Dear Dr. Anand Srivastava,
We are proud to announce that The World Congress of Biomedical Engineering-2017 (WCBME-2017) with a theme of “Co-creating a New Future of Biomedicine”, will be held during 9 to 11 November, 2017, Xi’an, China. On behalf of the organizing committee, we cordially welcome you to be the Speaker at Session 6-4: Stem Cells in Therapy. We believe that your participation will definitely highlight our event!
If the suggested thematic session is not your current focused core, you may look through the whole sessions and transfer another one that fit your interest (more info about the program is available at http://www.bitcongress.com/wcbme2017/programlayout.asp
BIT’s 1st World Congress of Biomedical Engineering-2017 …
BIT’s 1 st World Congress of . Bio medical Engineering 2017. Time: November 9-11, 2017 Place: Xi’an, China . Chapter 1: Main Conference
WCBME-2017 features a very strong technical program, mainly focused on: Biom echanics and Mechanobiology, Biomedical Imaging, Biomaterials, Biosensors and Bioelectronics, Cell and Tissue Engineering, Nanomedicine, Biomedical Optics, and cutting-edge Biomedical Instrumentation and Devices. It aims to provide a platform for all experts from academia, industry and national labs to discuss latest hot researches and achievements. Attendees will hear world-class speakers discussing the challenges and opportunities facing the biomedical engineering field. The business & academic experts who are from home and abroad will give excellent speeches.
In addition to the dynamic scientific program, you will benefit from the wonderful experience in Xi’an, China. Xi’an is the oldest of the Four Great Ancient Capitals, having held the position under several of the most important dynasties in Chinese history. We hope you will enjoy your stay in this beautiful city with all its feature, beauty, architecture and hospitality!
PS: We expect your precious comments or suggestions on the structure of our program, as well as your reference to other speakers that will be highly appreciated. We look forward to receiving your replies on the following questions:
For more information, please visit the conference website http://www.bitcongress.com/wcbme2017/default.asp
We look forward to seeing you in Xi’an in 2017 for this influential event!
Ms. Joyce Tan
Organizing Committee of WCBME2017
Add: East Wing, F11, Building 1,
Dalian Ascendas IT Park, 1 Hui Xian Yuan,
Dalian Hi-tech Industrial Zone,